Antibody production by human X human hybridomas in serum-free medium. 1985

S P Cole, and E H Vreeken, and J C Roder

Four human X human hybridomas were adapted to growth in serum-free medium consisting of RPMI 1640 supplemented with bovine serum albumin and transferrin (BSA/Tf medium). Production of specific monoclonal antibodies was maintained for more than 2 months. Although the maximal cell density achieved was lower than that in serum-supplemented medium, immunoglobulin production was similar or higher when results were expressed on a per viable cell basis. Thus it is feasible to grow human X human hybridomas in serum-free culture and it is possible that this will become the method of choice for large scale production of human monoclonal antibodies.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D013745 Tetanus Toxoid Tetanus Vaccine,Toxoid, Tetanus,Vaccine, Tetanus

Related Publications

S P Cole, and E H Vreeken, and J C Roder
January 1984, Eksperimental'naia onkologiia,
S P Cole, and E H Vreeken, and J C Roder
January 1980, Journal of immunological methods,
S P Cole, and E H Vreeken, and J C Roder
November 1987, In vitro cellular & developmental biology : journal of the Tissue Culture Association,
S P Cole, and E H Vreeken, and J C Roder
January 1991, Cytotechnology,
S P Cole, and E H Vreeken, and J C Roder
January 1988, BioTechniques,
S P Cole, and E H Vreeken, and J C Roder
July 2000, Cytotechnology,
S P Cole, and E H Vreeken, and J C Roder
November 1990, Cytotechnology,
S P Cole, and E H Vreeken, and J C Roder
February 1989, BioTechniques,
S P Cole, and E H Vreeken, and J C Roder
July 1983, Infection and immunity,
Copied contents to your clipboard!